STOCK TITAN

Harrow Announces Nashville Expansion

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags

Harrow Inc. (Nasdaq: HROW), a leading U.S. ophthalmic pharmaceutical company, has announced a significant expansion of its corporate headquarters in Nashville, Tennessee. The expansion will create nearly 150 new jobs in the area. Harrow, originally founded in San Diego in 2012, relocated its headquarters to Nashville in 2019.

Since the relocation, Harrow has invested in Nashville by building a state-of-the-art analytical chemistry lab, expanding its sales and marketing organization, and hiring for other critical business operations. The company has also recently expanded its total leased square footage in Nashville to approximately 30,000 square feet.

Tennessee Governor Bill Lee and other state officials praised the expansion, highlighting the state's growing economy and business-friendly environment. Harrow's CEO, Mark L. Baum, cited Nashville's advantageous location, beneficial tax environment, and dynamic culture as key factors in the company's decision to expand in the city.

Harrow Inc. (Nasdaq: HROW), una delle principali aziende farmaceutiche oftalmiche degli Stati Uniti, ha annunciato una significativa espansione della sua sede centrale a Nashville, Tennessee. L'espansione creerà quasi 150 nuovi posti di lavoro nella zona. Harrow, fondata inizialmente a San Diego nel 2012, ha trasferito la sua sede a Nashville nel 2019.

Dal trasferimento, Harrow ha investito a Nashville costruendo un laboratorio di chimica analitica all'avanguardia, espandendo la sua organizzazione di vendita e marketing, e assumendo per altre operazioni aziendali critiche. L'azienda ha anche recentemente ampliato la sua superficie totale affittata a Nashville a circa 30.000 piedi quadrati.

Il governatore del Tennessee Bill Lee e altri funzionari statali hanno elogiato l'espansione, mettendo in evidenza l'economia in crescita dello stato e l'ambiente favorevole per gli affari. Il CEO di Harrow, Mark L. Baum, ha citato la posizione vantaggiosa di Nashville, l'ambiente fiscale favorevole e la cultura dinamica come fattori chiave nella decisione dell'azienda di espandersi nella città.

Harrow Inc. (Nasdaq: HROW), una de las principales empresas farmacéuticas oftálmicas de EE. UU., ha anunciado una expansión significativa de su sede corporativa en Nashville, Tennessee. La expansión creará casi 150 nuevos empleos en la zona. Harrow, fundada originalmente en San Diego en 2012, trasladó su sede a Nashville en 2019.

Desde el traslado, Harrow ha invertido en Nashville construyendo un laboratorio de química analítica de última generación, ampliando su organización de ventas y marketing, y contratando para otras operaciones comerciales críticas. La empresa también ha ampliado recientemente su superficie total arrendada en Nashville a aproximadamente 30,000 pies cuadrados.

El gobernador de Tennessee, Bill Lee, y otros funcionarios estatales elogiaron la expansión, destacando la creciente economía del estado y su ambiente favorable para los negocios. El CEO de Harrow, Mark L. Baum, citó la ubicación ventajosa de Nashville, su entorno fiscal beneficioso y su cultura dinámica como factores clave en la decisión de la empresa de expandirse en la ciudad.

해로우 Inc. (Nasdaq: HROW), 미국의 주요 안과 제약 회사는 테네시주 내슈빌에 위치한 본사의 상당한 확장을 발표했습니다. 이 확장은 이 지역에 거의 150개의 새로운 일자리를 창출할 것입니다. 해로우는 2012년 샌디에이고에서 설립되어 2019년에 내슈빌로 본사를 이전했습니다.

이전 이후 해로우는 최첨단 분석 화학 실험실을 구축하고 판매 및 마케팅 조직을 확장하며 기타 중요한 비즈니스 운영을 위한 인력을 채용하는 등 내슈빌에 투자했습니다. 이 회사는 또한 최근 내슈빌에서 임대하는 총 면적을 약 30,000 평방피트로 늘렸습니다.

테네시 주지사 빌 리(Bill Lee)와 다른 주 정부 관계자들은 확대를 칭찬하며, 주의 성장하는 경제와 비즈니스 친화적인 환경을 강조했습니다. 해로우의 CEO 마크 L. 바움(Mark L. Baum)은 내슈빌의 유리한 위치, 유익한 세금 환경 및 역동적인 문화가 회사의 도시 확장 결정의 주요 요소라고 언급했습니다.

Harrow Inc. (Nasdaq: HROW), une entreprise pharmaceutique ophtalmique de premier plan aux États-Unis, a annoncé une expansion significative de son siège social à Nashville, Tennessee. Cette expansion créera près de 150 nouveaux emplois dans la région. Harrow, fondée à San Diego en 2012, a déplacé son siège à Nashville en 2019.

Depuis cette relocalisation, Harrow a investi à Nashville en construisant un laboratoire de chimie analytique à la pointe de la technologie, en élargissant son organisation commerciale et marketing, et en recrutant pour d'autres opérations commerciales critiques. L'entreprise a également récemment élargi sa superficie totale louée à Nashville à environ 30 000 pieds carrés.

Le gouverneur du Tennessee, Bill Lee, et d'autres fonctionnaires de l'État ont salué cette expansion, soulignant l'économie en pleine croissance de l'État et son environnement favorable aux affaires. Le PDG de Harrow, Mark L. Baum, a cité l'emplacement avantageux de Nashville, un environnement fiscal bénéfique, et une culture dynamique comme des facteurs clés dans la décision de l'entreprise d'étendre ses activités dans la ville.

Harrow Inc. (Nasdaq: HROW), ein führendes amerikanisches Unternehmen in der Augenheilkunde, hat eine bedeutende Erweiterung seines Unternehmenssitzes in Nashville, Tennessee, angekündigt. Die Erweiterung wird fast 150 neue Arbeitsplätze in der Region schaffen. Harrow wurde ursprünglich 2012 in San Diego gegründet und verlegte 2019 seinen Hauptsitz nach Nashville.

Seit der Verlagerung hat Harrow in Nashville investiert, indem es ein hochmodernes Labor für analytische Chemie gebaut, seine Vertriebs- und Marketingorganisation erweitert und Mitarbeiter für andere kritische Geschäftsbereiche eingestellt hat. Das Unternehmen hat auch kürzlich die gesamte angemietete Fläche in Nashville auf etwa 30.000 Quadratfuß erweitert.

Der Gouverneur von Tennessee, Bill Lee, und andere staatliche Beamte lobten die Erweiterung und hoben die wachsende Wirtschaft des Staates sowie das geschäftsfreundliche Umfeld hervor. Der CEO von Harrow, Mark L. Baum, nannte die vorteilhafte Lage von Nashville, das günstige Steuerumfeld und die dynamische Kultur als entscheidende Faktoren für die Entscheidung des Unternehmens, in der Stadt zu expandieren.

Positive
  • Creation of nearly 150 new jobs in Nashville
  • Expansion of corporate headquarters, including a state-of-the-art analytical chemistry lab
  • Increased leased square footage to approximately 30,000 square feet
  • Potential for improved service to eyecare professionals throughout North America
Negative
  • None.

Leading U.S. ophthalmic pharmaceutical company to create nearly 150 new jobs in Nashville

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Tennessee Governor Bill Lee, Department of Economic and Community Development Commissioner Stuart C. McWhorter, and Mark L. Baum, Chief Executive Officer of Harrow, Inc. (Nasdaq: HROW), announced today that Harrow is expanding its corporate headquarters in Nashville.

Harrow was originally founded in 2012 in San Diego, California. In 2019, Harrow relocated its corporate headquarters to Nashville, Tennessee. Since 2019, Harrow has continued to invest in Nashville by building a state-of-the-art analytical chemistry lab, expanding its sales and marketing organization, and hiring for other critical business operations. Harrow also recently expanded its total leased square footage in Nashville to approximately 30,000 square feet.

“Tennessee is leading the nation with one of the fastest growing economies because of companies like Harrow which have chosen to relocate and expand in our state. I look forward to seeing the positive impact these nearly 150 jobs will have on the skilled workforce across Nashville and Davidson County and congratulate Harrow on this win for our city.” – Gov. Bill Lee

“Harrow’s decision to expand its pharmaceutical operations right here in Nashville is a testament to the city’s business-friendly climate, low taxes and central location. Nashville has the potential to become the epicenter for healthcare in the U.S., and we are one step closer thanks to this company’s continued investment.” – TNECD Commissioner Stuart C. McWhorter

“Investing in Nashville has proven to be an exceptional decision for our company, my family, and the extended Harrow Family. Nashville’s advantageous location, beneficial tax environment, dynamic culture of innovation and entrepreneurship, dedication to personal freedoms, and its warm, community-spirited residents, establish it as the ultimate destination for business in America. With a shiny new airport, world-class universities, affordable housing and low property taxes, the energy and spirit of our city-center, and so much more, it’s the ideal place for attracting elite talent and realizing one’s entrepreneurial ambitions. Harrow’s Nashville expansion will not only improve our service to eyecare professionals throughout North America but also solidifies our dedication to the community that we are honored and thankful to call our home. For both Harrow and Nashville, the future has never been brighter.” – Mark L. Baum, Chief Executive Officer, Harrow, Inc.

“TVA and Nashville Electric Service congratulate Harrow on its decision to expand operations in Nashville. It’s always an exciting day when we can celebrate a company’s commitment to continued growth in the region. We are proud to partner with the Nashville Area Chamber of Commerce, Metropolitan Government of Nashville and Davidson County, and the Tennessee Department of Economic and Community Development to support companies like Harrow, and we look forward to its continued business success.” – John Bradley, TVA senior vice president of economic development

“District 20 proudly welcomes Harrow’s continued investment in our community, creating good, new jobs and expanding Tennessee’s healthcare science sector. This growth is a testament to the coordinated efforts of our state, local governments, and universities, who are preparing the workforce needed to secure such vital investments in our future.” – Sen. Heidi Campbell (D‑Nashville)

“I’m very excited about the expansion by Harrow and their investment in the community. I’m thankful for their continued belief in Nashville and its strong business environment and welcome the roughly 150 new jobs coming to the area.” – Rep. Bob Freeman (D-Nashville)

About Harrow, Inc.

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non‑prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

About the Tennessee Department of Economic and Community Development

The Tennessee Department of Economic and Community Development’s mission is to develop strategies that help make Tennessee the No. 1 location in the Southeast for high quality jobs. To grow and strengthen Tennessee, the department seeks to attract new corporate investment to the state and works with Tennessee companies to facilitate expansion and economic growth. Find us on the web: tnecd.com. Follow us on Twitter, Instagram and LinkedIn. Like us on Facebook. Subscribe to our YouTube channel.

Harrow:

Jamie Webb

Director of Communications and Investor Relations

(615) 733-4737

jwebb@harrowinc.com

TNECD Media:

Chris O’Brien

Public Information Officer

(615) 934-5879

Chris.OBrien@tn.gov

Source: Harrow, Inc.

FAQ

How many new jobs will Harrow (HROW) create in Nashville?

Harrow (HROW) will create nearly 150 new jobs in Nashville as part of its corporate headquarters expansion.

When did Harrow (HROW) relocate its headquarters to Nashville?

Harrow (HROW) relocated its corporate headquarters from San Diego to Nashville in 2019.

What facilities has Harrow (HROW) built in Nashville since relocating?

Since relocating to Nashville, Harrow (HROW) has built a state-of-the-art analytical chemistry lab and expanded its sales and marketing organization.

How much square footage does Harrow (HROW) now lease in Nashville?

Harrow (HROW) has recently expanded its total leased square footage in Nashville to approximately 30,000 square feet.

Harrow, Inc.

NASDAQ:HROW

HROW Rankings

HROW Latest News

HROW Stock Data

1.58B
35.48M
14.04%
54.19%
15.34%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
NASHVILLE